Back to Results
First PageMeta Content
MicroRNA / Non-coding RNA / RNA / European Association for the Study of the Liver / Hepatitis C virus / Genetics / Biology / MiR-122


A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients
Add to Reading List

Open Document

File Size: 2,04 MB

Share Result on Facebook

City

Amsterdam / Zuidlaren / San Diego / Groningen / /

Company

Clinical Virology Laboratory / /

Country

Netherlands / /

Currency

pence / /

Facility

Academic Medical Center / University Medical Center Groningen / /

MedicalCondition

HIV / HBV / hepatocellular carcinoma / Chronic HCV infection / liver disease / chronic hepatitis C / fibrosis / hepatitis C / HCV / HCV genotype / HCV RNA / /

Person

H. van der Ree / /

Product

W8 / /

Technology

Drug Discovery / genotype / /

SocialTag